To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at For Technical questions please contact Thank you.

Privacy Policy Update

We remain dedicated to protecting your data and experience throughout our platforms. We have updated our Privacy Policy and your continued use of the Site means you have accepted the revised Privacy Policy. View now >

Blood Cancer

Liquid tumors formed by hematopoietic progenitor cells or other components of blood and bone marrow result in anemia, bleeding disorders, a compromised immune system, and premature death. ATCC provides numerous cell lines and cell culture reagents focused on advancing blood cancer research areas such as leukemia, lymphoma, and myeloma.  The ATCC collection includes:

Bone Marrow and Blood

ATCC’s vast collection of cell lines derived from bone marrow cells represent multiple species and a variety of immunological and cardiovascular cells. These cells are classed as either bone marrow or blood tissue. They originate in the bone marrow and then migrate into blood circulation, lymphatic circulation, and lymphatic tissues.

Bone Marrow Cells
Blood Cells

Hematopoietic Primary Cells

ATCC has primary hematopoietic cells useful as controls for continuous cell lines. These cells may also be differentiated into various hematopoietic lineages for use in examining disease pathogenesis or drug development studies. This collection includes hematopoietic progenitor cells, monocytes, and mononuclear cells.

Hematopoietic Cells

Tumor Cell Panels

ATCC Tumor Cell Panels combine authenticated, well-characterized cell lines with mutation data from the Sanger Institute Catalogue of Somatic Mutations in Cancer (COSMIC). The leukemia and lymphoma Tumor Cell Panel offerings provide subtype-specific collections of cells to improve the pace of your research.

Leukemia Tumor Cell Panels
Lymphoma Tumor Cell Panels